Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation

Amy Schneeberg, Julie A Bettinger, Shelly McNeil, Brian J Ward, Marc Dionne, Curtis Cooper, Brenda Coleman, Mark Loeb, Ethan Rubinstein, Janet McElhaney, David W Scheifele, Scott A Halperin, Amy Schneeberg, Julie A Bettinger, Shelly McNeil, Brian J Ward, Marc Dionne, Curtis Cooper, Brenda Coleman, Mark Loeb, Ethan Rubinstein, Janet McElhaney, David W Scheifele, Scott A Halperin

Abstract

Background: Fewer Canadian seniors are vaccinated against pneumococcal disease than receive the influenza vaccine annually. Improved understanding of factors influencing pneumococcal vaccination among older adults is needed to improve vaccine uptake.

Methods: A self-administered survey measuring knowledge, attitudes, beliefs and behaviours about pneumococcal vaccination was administered to a cohort of seniors participating in a clinical trial of seasonal influenza vaccines at eight centers across Canada. Eligible participants were ambulatory adults 65 years of age or older, in good health or with stable health conditions, previously given influenza vaccine. The primary outcome was self-reported receipt of pneumococcal vaccination. Multi-variable logistic regression was used to determine factors significantly associated with pneumococcal vaccine receipt.

Results: A total of 863 participants completed questionnaires (response rate 92%); 58% indicated they had received the pneumococcal vaccine. Being offered the vaccine by a health care provider had the strongest relationship with vaccine receipt (AOR 23.4 (95% CI 13.4-40.7)). Other variables that remained significantly associated with vaccine receipt in the multivariable model included having heard of the vaccine (AOR 10.1(95% CI 4.7-21.7)), and strongly agreeing that it is important for adults > 65 to be vaccinated against pneumococcus (AOR 3.3 (95% CI 1.2-9.2)). Participants who were < 70 years of age were less likely to be vaccinated.

Conclusions: These results indicate healthcare recommendation significantly influenced vaccine uptake in this population of older adults. Measures to encourage healthcare providers to offer the vaccine may help increase coverage.

References

    1. Public Health Agency of Canada. Vaccine Preventable Diseases: Invasive Pneumococcal Disease. 2011. .
    1. Kohlhammer Y, Schnoor M, Schwartz M, Raspe H, Schäfer T. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health. 2007;121:742–51. doi: 10.1016/j.puhe.2007.02.011.
    1. Group ER. Canadian Adult National Immunization Coverage (Adult NICS) Survey. 2006.
    1. Public Health Agency of Canada (PHAC) Canadian Immunization Guide - Public Health Agency of Canada. 2007.
    1. Pfizer Canada Inc. Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) Product Monograph. Kirkland; 2014.
    1. National Advisory Committee on Immunization - Public Health Agency of Canada. Update on the use of conjugate pneumococcal vaccines in childhood. Canada Commun Dis Rep. 2010.
    1. Frenck RW, Yeh S. The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults. Expert Opin Biol Ther. 2012;12:63–77. doi: 10.1517/14712598.2012.636348.
    1. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211. doi: 10.1016/0749-5978(91)90020-T.
    1. Janz NK, Becker MH. The health belief model: a decade later. Heal Educ Behav. 1984;11:1–47. doi: 10.1177/109019818401100101.
    1. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95. doi: 10.1503/cmaj.050051.
    1. Nichol KL, Mac Donald R, , Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med. 1996;11:673–7. doi: 10.1007/BF02600158.
    1. Evans MR, Watson P. Why do older people not get immunised against influenza? a community survey. Vaccine. 2003;21:2421–2427. doi: 10.1016/S0264-410X(03)00059-8.
    1. Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000–2001) J Am Geriatr Soc. 2004;52:25–30. doi: 10.1111/j.1532-5415.2004.52006.x.
    1. Ehresmann KR, Ramesh A, Como-Sabetti K, Peterson DC, Whitney CG, Moore KA. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Prev Med (Baltim) 2001;32:409–15. doi: 10.1006/pmed.2001.0839.
    1. Lau D, Hu J, Majumdar SR, Storie DA, Rees SE, Johnson JA. Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Ann Fam Med. 2012;10:538–46. doi: 10.1370/afm.1405.
    1. Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ. 2009;180:48–58. doi: 10.1503/cmaj.080734.
    1. Wagner C, Popp W, Posch M, Vlasich C, Rosenberger-Spitzy A. Impact of pneumococcal vaccination on morbidity and mortality of geriatic patients: a case-controlled study. Gerontology. 2003;49(4):246–250. doi: 10.1159/000070405.
    1. Sharpiro E, Berg A, Austrian R, Schroeder D, Parcells V, Margolis A, Adair R, JD C. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325(21):1453–60. doi: 10.1056/NEJM199111213252101.
    1. Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis. 2014;58:909–17. doi: 10.1093/cid/ciu002.
    1. Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the community-acquired pneumonia organi. Vaccine. 2014;32:2198–203. doi: 10.1016/j.vaccine.2014.02.048.
    1. Mieczkowski TA, Wilson SA. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine. 2002;20:1383–1392. doi: 10.1016/S0264-410X(01)00463-7.
    1. Szilagyi PG, Shone LP, Barth R, Kouides RW, Long C, Humiston SG, Jennings J, Bennett NM. Physician practices and attitudes regarding adult immunizations. Prev Med (Baltim) 2005;40:152–61. doi: 10.1016/j.ypmed.2004.05.010.
    1. Mui LWH, Chan AYS, Lee A, Lee J. Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong. PLoS One. 2013;8:e78210. doi: 10.1371/journal.pone.0078210.
    1. Sintes X, Nebot M, Izquierdo C, Ruiz L, Dominguez A, Bayas JM, Vera I, Carratala J, Sousa D. Factors associated with pneumococcal and influenza vaccination in hospitalized people aged 65 years. Epidemiol Infect. 2011;139:666–673. doi: 10.1017/S0950268810001846.
    1. Christenson B, Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect. 2002;129:515–24. doi: 10.1017/S095026880200780X.
    1. Lu P, Nuorti JP. Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989–2008. Am J Prev Med. 2010;39:287–95. doi: 10.1016/j.amepre.2010.06.004.
    1. Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. Heal Psychol. 2007;26:136–45.
    1. Wong-Beringer A, Brodetsky E, Quist R. Pneumococcal vaccination in hospitalized elderly patients: role of the pharmacist. Pharmacotherapy. 2003;23:199–208. doi: 10.1592/phco.23.2.199.32085.

Source: PubMed

3
구독하다